Compare Micron Technology, Inc. (MU) vs TG Therapeutics Inc (TGTX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Micron Technology, Inc. vs TG Therapeutics Inc — how do they compare? Micron Technology, Inc. trades at $987.2 (market cap $977.44B), while TG Therapeutics Inc trades at $54.06 (market cap $8.26B). The key difference: Micron Technology, Inc. is far larger — about 118.3× TG Therapeutics Inc's market cap, and Micron Technology, Inc. pays a 0.06% dividend while TG Therapeutics Inc pays none. Which is the better fit depends on your goals.
| MU | TGTX | |
|---|---|---|
Market Cap | $977.44B | $8.26B |
Sector | Technology | Health |
52-Week High | $1.21K | $59.06 |
52-Week Low | $104.88 | $26.39 |
Enterprise Value | $957.80B | $8.50B |
Dividend Yield | 0.06% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Micron Technology, Inc.
Micron historically focused on designing and manufacturing DRAM for PCs. The firm then expanded into the NAND flash memory market. It increased its DRAM scale with the purchase of Elpida (completed in mid-2013) and Inotera (completed in December 2016). The firm's DRAM and NAND products tailored to PCs, data centers, smartphones, game consoles, automotives, and other computing devices.
Read more on MU →About TG Therapeutics Inc
TG Therapeutics is a fully integrated biopharmaceutical company focused on the acquisition, development, and commercialization of novel treatments for B-cell mediated diseases. Its cornerstone product, BRIUMVI (ublituximab-xiiy), is a glycoengineered monoclonal antibody approved for relapsing forms of multiple sclerosis. The company is currently executing a 'pipeline-in-a-product' strategy, expanding BRIUMVI into new delivery methods and indications while advancing a broader portfolio of autoimmune and oncology candidates.
Read more on TGTX →
